Article Details

Roche's neuromyelitis optica drug Enspryng wins EU approval

Retrieved on: 2021-06-28 06:22:30

Tags for this article:

Click the tags to see associated articles and topics

Roche's neuromyelitis optica drug Enspryng wins EU approval. View article details on hiswai:

Excerpt

... last August to treat the rare condition, also called Devic's disease, where the immune system damages the spinal cord and the nerves of the eyes.

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up